Main Characteristics

SPECIALIZATION:

   Exclusively working in Lentivirus

CDMO BUSINESS MODEL:

Covering the different phases

QUALITY-BASED COMPANY:

Sealed as Excellence Centre by European Union

SCIENTIFIC EXPERTISE:

Own Lentivirus-based technology (Lentisoma)

CUSTOMIZED APPROACH TO PROJECTS:

From the technical and timelines point of view

BROAD EXPERTISE AND EXPERIENCE OF OUR TEAM:

More than 2000 Lentiviral batches manufactured

THE MOST INNOVATIVE EQUIPMENTS AVAILABLE:

  • iCELLis-nano bioreactor technology
  • Compatible equipment at R&D and GMP suites
  • USP+DSP
  • More than 800 sqm labs

MANUFACTURING PLATFORM DEVELOPMENT:

  • Improved transient transfection method
  • Increased final yield compared with regular protocols

POTENTIALITY:

Capacities, capabilities and infrastructure to increase current capacity.

INTERNATIONAL COMPANY:

US and European Customers

Contact with us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)

  • dummy+34 943 308 568

  • dummy info@vivebiotech.com

Retos project